190 related articles for article (PubMed ID: 24098450)
1. Lumican - derived peptides inhibit melanoma cell growth and migration.
Pietraszek K; Brézillon S; Perreau C; Malicka-Błaszkiewicz M; Maquart FX; Wegrowski Y
PLoS One; 2013; 8(10):e76232. PubMed ID: 24098450
[TBL] [Abstract][Full Text] [Related]
2. Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration.
Zeltz C; Brézillon S; Perreau C; Ramont L; Maquart FX; Wegrowski Y
FEBS Lett; 2009 Sep; 583(18):3027-32. PubMed ID: 19686741
[TBL] [Abstract][Full Text] [Related]
3. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes.
Brézillon S; Radwanska A; Zeltz C; Malkowski A; Ploton D; Bobichon H; Perreau C; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
Cancer Lett; 2009 Sep; 283(1):92-100. PubMed ID: 19394140
[TBL] [Abstract][Full Text] [Related]
4. Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins.
Brézillon S; Pietraszek K; Maquart FX; Wegrowski Y
FEBS J; 2013 May; 280(10):2369-81. PubMed ID: 23438179
[TBL] [Abstract][Full Text] [Related]
5. Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
Stasiak M; Boncela J; Perreau C; Karamanou K; Chatron-Colliet A; Proult I; Przygodzka P; Chakravarti S; Maquart FX; Kowalska MA; Wegrowski Y; Brézillon S
PLoS One; 2016; 11(3):e0150226. PubMed ID: 26930497
[TBL] [Abstract][Full Text] [Related]
6. Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach.
Dauvé J; Belloy N; Rivet R; Etique N; Nizet P; Pietraszek-Gremplewicz K; Karamanou K; Dauchez M; Ramont L; Brézillon S; Baud S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638415
[TBL] [Abstract][Full Text] [Related]
7. Lumican: a new inhibitor of matrix metalloproteinase-14 activity.
Pietraszek K; Chatron-Colliet A; Brézillon S; Perreau C; Jakubiak-Augustyn A; Krotkiewski H; Maquart FX; Wegrowski Y
FEBS Lett; 2014 Nov; 588(23):4319-24. PubMed ID: 25304424
[TBL] [Abstract][Full Text] [Related]
8. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.
Sifaki M; Assouti M; Nikitovic D; Krasagakis K; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Oct; 58(10):606-10. PubMed ID: 17050378
[TBL] [Abstract][Full Text] [Related]
9. Lumican inhibits cell migration through α2β1 integrin.
Zeltz C; Brézillon S; Käpylä J; Eble JA; Bobichon H; Terryn C; Perreau C; Franz CM; Heino J; Maquart FX; Wegrowski Y
Exp Cell Res; 2010 Oct; 316(17):2922-31. PubMed ID: 20705068
[TBL] [Abstract][Full Text] [Related]
10. Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14.
Malinowski M; Pietraszek K; Perreau C; Boguslawski M; Decot V; Stoltz JF; Vallar L; Niewiarowska J; Cierniewski C; Maquart FX; Wegrowski Y; Brézillon S
PLoS One; 2012; 7(12):e50709. PubMed ID: 23236386
[TBL] [Abstract][Full Text] [Related]
11. The small leucine-rich proteoglycan lumican inhibits melanoma progression.
Vuillermoz B; Khoruzhenko A; D'Onofrio MF; Ramont L; Venteo L; Perreau C; Antonicelli F; Maquart FX; Wegrowski Y
Exp Cell Res; 2004 Jun; 296(2):294-306. PubMed ID: 15149859
[TBL] [Abstract][Full Text] [Related]
12. Lumican inhibits B16F1 melanoma cell lung metastasis.
Brezillon S; Zeltz C; Schneider L; Terryn C; Vuillermoz B; Ramont L; Perrau C; Pluot M; Diebold MD; Radwanska A; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():15-22. PubMed ID: 20083847
[TBL] [Abstract][Full Text] [Related]
13. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar.
Li Y; Aoki T; Mori Y; Ahmad M; Miyamori H; Takino T; Sato H
Cancer Res; 2004 Oct; 64(19):7058-64. PubMed ID: 15466200
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.
Ishiwata T; Yamamoto T; Kawahara K; Kawamoto Y; Matsuda Y; Ishiwata S; Naito Z
Exp Mol Pathol; 2010 Jun; 88(3):363-70. PubMed ID: 20138170
[TBL] [Abstract][Full Text] [Related]
16. Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican.
D'Onofrio MF; Brézillon S; Baranek T; Perreau C; Roughley PJ; Maquart FX; Wegrowski Y
Biochem Biophys Res Commun; 2008 Jan; 365(2):266-72. PubMed ID: 17981144
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization.
Radwanska A; Litwin M; Nowak D; Baczynska D; Wegrowski Y; Maquart FX; Malicka-Blaszkiewicz M
Exp Cell Res; 2012 Nov; 318(18):2312-23. PubMed ID: 22814255
[TBL] [Abstract][Full Text] [Related]
18. Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity.
Nikitovic D; Chalkiadaki G; Berdiaki A; Aggelidakis J; Katonis P; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2011 Jun; 43(6):928-35. PubMed ID: 21421073
[TBL] [Abstract][Full Text] [Related]
19. Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes.
Melching LI; Roughley PJ
Matrix Biol; 1999 Aug; 18(4):381-90. PubMed ID: 10517185
[TBL] [Abstract][Full Text] [Related]
20. Lumican affects actin cytoskeletal organization in human melanoma A375 cells.
Radwanska A; Baczynska D; Nowak D; Brézillon S; Popow A; Maquart FX; Wegrowski Y; Malicka-Blaszkiewicz M
Life Sci; 2008 Nov; 83(19-20):651-60. PubMed ID: 18848571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
